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ABSTRACT 
Background: Autosomal dominant polycystic 
kidney disease is a condition mainly character-
ized by the progressive development and enlar- 
gement of cysts in each kid neys. In this process 
a high rate of proliferation and apoptosis of tu-
bular cells has been documented and inter-
preted as a futile attempt of tissue repair. In 
consideration of the role of stem cells in repara-
tive processes we investigated the presence and 
localization of CD133 + CD24+ renal progenitors 
in renal ADPKD tissue and cells. Methods: Two 
normal kidneys and two ADPKD kidneys were 
examined. CD133 and CD24 expression was in-
vestigated by confocal microscopy and immu- 
noblotting. Furthermore cystic isolated cells and 
cultured immortalized cells were characterized. 
Results: CD133 and CD24 have the same local- 
ization in ADPKD tissues and in normal kidneys: 
expression is restricted to a subset of epithelial 
cells (PEC) of Bowman’s capsule and to tubular 
cells in a focal and segmental pattern. Further- 
more, in ADPKD tissue, cysts diffusely express 
CD133 and CD24. According to a quantitative 
analysis in ADPKD tissue CD133 + CD24 + cells 
are statistically more expressed in tubules (p < 
0.001) and less expressed in the Bowman’s 
capsule (p = 0.0016) compared to the same lo- 
calizations in control tissue. Conclusions: CD133 
and CD24 antigens, typically expressed by renal 
epithelial progenitors, are more expressed in 
ADPKD tubules and highly expressed in ADPKD 
cysts. Whether CD133 and CD24 expression 
would signify renal progenitor recruitment or 
alternatively an expression pattern of the dedif-
ferentiation of ADPKD cells remains unclear. 
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1. INTRODUCTION 
Autosomal Dominant Polycystic Kidney Disease 
(ADPKD) can arise from mutations in either PKD1 (85% 
of affected patients) or PKD2 (15% of affected patients) 
genes with clinically indistinguishable manifestations [1]. 
ADPKD affects over 1:1000 of the world wide popula-
tion and it causes 1:3000 hospitalization. ADPKD is as-
ymptomatic in about 50% of subjects with pkd genes 
mutated [2]. It is a systemic disease associated with renal 
failure, intracranial arterial aneurysms, cardiac valvular 
defects, colonic diverticulosis and cyst formation in other 
organs such as the liver, spleen and pancreas. Neverthe-
less ADPKD gives mainly renal manifestations: the pa-
tients develop renal cysts which progressively lead to 
disruption of renal parenchyma, interstitial fibrosis, cel-
lular infiltration and loss of functional nephrons. Renal 
degeneration finally progresses to end-stage renal disease 
[1].  
PKD1 (located on chromosome 16) codes for a large 
transmembrane protein of 460 KDa involved in the con- 
trol of calcium permeation and cell-cell/matrix interac- 
tion. PKD2 (located on chromosome 4) codes for a cal- 
cium channel of about 110 KDa. The polycystin 1 and 2 
(the proteins were coded by PKD1 and PKD2 genes) 
collaborate together in a functional complex [3,4]. 
Previous studies have demonstrated a high rate of pro-
liferation and apoptosis in the cysts of ADPKD patients4 
and this phenomenon has been interpreted as an unpro-
ductive attempt of tissue reparation. In this scenario a 
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likely involvement of renal progenitors can be hypothe-
sized. 
Sagrinati et al. identified, in human adult kidneys, a 
subset of Parietal Epithelial Cells (PECs) in the Bow-
man’s capsule that revealed self-renewal potential and 
high cloning efficiency. This subset of PECs exhibits co- 
expression of stem cell markers CD24 and CD133 and 
absence of lineage-specific markers. Under appropriate 
culture conditions, individual clones of CD24 + CD133 + 
PEC could be induced to generate mature, functional, 
tubular cells with phenotypic features of proximal and/or 
distal tubules [5]. 
ADPKD is characterized by expansion of cysts and 
tubular hyperplasia in the context of a sustained prolif-
erative and apoptotic process. In this brief report we ex-
plored the pathologic features of presumptive renal pro-
genitor cells in ADPKD renal tissue trying to explain the 
nature of their involvement in the disease: tissue repair or 
increase of cystic lesions. 
2. RESULTS 
2.1. Expression of CD133 and CD24 in  
Normal and ADPKD Kidney 
In normal kidney at the glomerular level the confocal 
microscopic analysis shows that CD133 and CD24 are 
co-expressed by a subset of parietal epithelial cells (PEC) 
in the Bowman’s capsule (Figure 1: on line publication): 
CD24 has a generalized and diffuse presentation, CD133 
is generalized and segmental. At tubular level the distri-
bution of the expression of both CD133 and CD24 is 
focal and global. In the normal kidney specimen the 
overall intensity of CD24 + cells have the similar median 
value compared to CD133 + cells but the distribution of 
the intensity for the CD24 + cells is larger (Figure 2(a): 
on line publication). In the ADPKD kidney specimen the 
overall intensity of CD133 is higher, but not statistically 
significant, than the intensity of CD24 + cells (Figure 
2(b): on line publication). It is interesting to note that at 
cellular level CD133 is polarized to the luminal side of 
the tubular cell surface as well to the urinary space side 
in positive PECs, whereas CD24 is not clearly polarized 
but shows a diffuse distribution at the membrane and 
cytoplasm level (Figure 1: on line publication). 
Analysis of confocal microscopy of ADPKD kidneys 
revealed that CD133 and CD24 were expressed in a sub-
set of glomerular (Figures 3(a)-(c)) and tubular (Figures 
3(d)-(f)) cells and they showed the same tissue of normal 
kidney [5]: CD133 presents a generalized and segmental 
pattern while CD24 is generalized and diffuse in the 
Bowman’s capsule. The expression of both CD133 and 
CD24 is focal and global in the tubules. 
The cysts of ADPKD samples showed a segmental  
 
Figure 1. CD133 and CD24 expression in normal kid- 
ney. The first lane shows tissue expression of CD133 
in Bowman’s capsules and tubules. CD133 is ex- 
pressed in a subset of PEC in the Bowman’s capsule 
and in the luminal side of positive tubular cells. The 
second lane shows tissue expression of CD24 in 
Bowman’s capsules and tubules. CD24 is expressed in 
a subset of PEC in the Bowman’s capsule and in the 
cytoplasm of tubular cells. 
 
 
Figure 2. Morphometric analysis of CD24 and CD133 global 
expression (a) in normal kidney and (b) in ADPKD kidney. (a) 
In normal tissue, CD24 and CD133 the median expression is 
similar, even though CD24 intensity has a larger distribution 
than CD133; (b) In ADPKD tissue, CD133 expression is higher 
than that of CD24. 
 
co-expression pattern of CD133 and CD24. CD24 has a 
generalized distribution in the samples while CD133 is 
segmental. The cells of large cysts show a flatted mor-
phology and a co-localization of CD133 and CD24 can 
be appreciated in some segments (Figures 3(g)-(i)). 
The quantitative comparison between normal kidney 
and ADPKD kidney revealed an increased CD133 ex-
pression in tubules while glomerular expression appears  
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Figure 3. CD133 and CD24 expression in ADPKD samples. 
The first lane shows glomerular expression of CD133 (a) and 
CD24 (b). CD133 and CD24 are co-localized and co-expressed 
by a subset of PEC in the Bowman’s capsule (c). The second 
lane shows tubular expression of CD133 (d) and CD24 (e). 
CD133 and CD24 are co-expressed in these tubules (f). The 
third lane shows cystic expression of CD133 (g) and CD24 (h). 
CD133 and CD24 are co-localized and co-expressed by the 
cystic cells (i). 
 
reduced in ADPKD samples (Figure 4). After image 
analysis Mann-Whitney test resulted statistically signifi-
cant for these comparisons (ADPKD tubules vs Normal 
tubules: z = −7.681 p < 0.001; ADPKD Glomerula vs 
Normal Glomerula: z = 3.162 p = 0.0016). CD 24 ex-
pression in glomerular and tubules does not show quan-
titative difference between normal and ADPKD samples 
(Figure 4). 
2.2. Expression of CD133 and CD24 in  
Cultured Cells 
Cells deriving from the cystic wall of ADPKD tissue 
were scraped and expanded in culture. The epithelial na- 
ture of these cells was confirmed by cytocheratin immu- 
nohistochemical characterization (Figure 5 and Table 1: 
on line publication). In the subsequent analyses were 
used the clones of isolated cells that showed the com- 
plete expression of the cytokeratins (CAM 5.2, CK 7, 
MNF 116) usually expressed by cystic cells in tissue 
specimens. 
Isolated cystic cells show a characteristic expression  
 
Figure 4. Morphometric analysis of CD133 and CD24 expres-
sion in tubules and glomerula of normal kidney and ADPKD 
kidney. CD133 expression is higher in ADPKD tubules than in 
normal tubules (*p < 0.001). (a) CD133 expression is reduced 
in ADPKD glomerula compared to normal glomerula (#p = 
0.0016); (b) CD24 expression is not statistically different in 
both normal tubules vs ADPKD tubules (c) and normal glome-
rula vs ADPKD glomerula (d) comparison. 
 
 
Figure 5. Example of cytokeratin expression (CK 7) in cultured 
cystic cells and in cyst. Immunohistochemical analysis reveals 
that both cultured cystic cells (A) and cystic epithelium (B) 
express CK 7. 
 
pattern for CD133 and CD24 (Figures 6(A)-(C): on line 
publication). CD133 is localized on the cellular mem-
brane (Figure 6(A): on line publication) while CD24 is 
globally diffused in the cytoplasm (Figure 6(B): on line  
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Table 1. Immunohistochemical analysis of cytokeratin expres- 
sion in ADPKD tissue. (1) Focal and global distribution; (2) 
Focal and segmental distribution. 
 CAM 5.2 CK 7 CK 20 MNF 116
Bowman’s Capsule - + (2) - + (2) 
Tubules + (1) + (1) - + (1) 
Cysts + (2) + (2) - + (2) 
 
 
Figure 6. CD133 and CD24 expression in cystic cells in colture. 
CD133 is closely expressed by the cellular membrane (A). 
CD24 is expressed in the cytoplasm (B). CD133 and CD24 are 
co-expressed by the cystic cells (C). 
 
publication). The expression of CD24 is more diffuse 
while few cells are CD133+; only a small subset of iso-
lated cystic cells are both CD133 and CD24 positive. 
The same expression pattern is appreciable in HK-2 
cell line while in HEK-293 cell line this peculiar pattern 
is lacking, both antigens presenting a cytoplasmic distri-
bution (Figure 7: on line publication). 
By western blot analysis CD133 is highly expressed 
by cystic cells, HK-2 presents an intermediate level of 
expression while HEK-293 cell line shows an almost 
absent expression (Figure 8). Analogous amounts of 
CD24 can be detected in the three cellular populations 
(Figure 8). 
3. DISCUSSION 
The high rate of proliferation and apoptosis of cystic 
cells is a well known phenomenon in ADPKD [4]. It has 
been interpreted as an unsuccessful proliferative repair 
response of abnormal tubular cells degenerating into cyst 
formation. The abnormal behavior of the tubule in 
ADPKD patients origins from genetic ablation of a criti-
cal function of the polycystin proteins and primary cilia 
[6,7]. This system is supposed to act as a sensor for renal 
injury monitoring the urinary intratubular flux. Accord-
ing to this model an abnormal constitutive activation of 
this pathway in ADPKD leads to the futile (proliferative) 
attempt to repair an essentially non existing injury [4]. 
In this scenario where proliferation and renal tissue 
repair are active we could speculate a possible role for 
renal progenitors. The target of our report has been an 
explorative analysis of surface antigens related to stem- 
ness in ADPKD tissue. A multipotent progenitor cell  
 
Figure 7. CD133 and CD24 expression in cellular lines. HK- 
2 show a similar antigen-expression pattern to cystic cells: 
CD133 is localized on the cellular membrane and CD24 is 
localized in the cytoplasm. HEK-293 have a diffused and 
low cellular expression of CD133 and CD24. 
 
 
Figure 8. Western blot analysis of CD133 and CD24 
expression in untreated HEK-293, HK-2 and cystic cells. 
Cystic cells express the highest amount of CD133 
whereas HEK-293 the lowest. CD24 amount is similar 
in the three populations. 
 
population constituted by CD24+ and CD133+ parietal 
epithelial cells (PECs), in adult human glomerula has 
been described. In this report a murine model of acute 
renal failure caused by glycerol induced rhabdomiolysis 
has been generated and injection of CD24+ and CD133+ 
PECs differentiated into tubular cells significantly ame-
liorating kidney damage 5. CD133 is a pentaspan trans-
membrane glycoprotein suspected to have a role in 
maintaining stem cell properties by suppressing differen-
tiation and promoting proliferation. CD133 expression is 
also associated to several types of cancer [8-10]. CD133 
function is not clear but its presence on early and undif-
ferentiated cells is suggestive of a growth factor receptor, 
and the presence of five tyrosine residues on the 50-aa 
cytoplasmic tail may indicate that the protein is phos-
phorylated in response to ligand binding and triggers a 
signal transduction [11]. CD24 is a sialoglycoprotein ex- 
pressed on mature granulocytes [12], B and T lympho- 
cyte subsets [13,14], normal and cancer stem cells 
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[15,16]. The protein is anchored via a glycosyl phos- 
phatidylinositol to cell surface. It acts as adhesion mole- 
cule and is involved in cell migration and signal trans- 
duction. 
In our specimens we could appreciate the presence of 
a rich CD24+ and CD 133+ cell population. In ADPKD 
the distribution of these cells is qualitatively similar to 
normal tissue with the notable exception of a significant 
expression in cystic cells. Quantitatively CD 133+ cell 
population appears globally increased in ADPKD tissue. 
In particular we found a statistically significant increase 
of CD133 expression in tubules while glomerular ex- 
pression appears reduced in ADPKD compared to control 
tissue. In this scenario the speculative hypothesis of an ac- 
tive migration of progenitors from the glomerular “niche” 
[17] to the tubule interstitial compartment is intriguing.  
The abundant presence of CD133+ and CD24+ cells in 
ADPKD renal tissue sustains the hypothesis of an im- 
portant role of this cell population in the disease. In- 
flammation and tubular damage are common features of 
ADPKD and CD133+ and CD24+ cells could likely play 
a role in the reparative process. Furthermore the diffuse 
presence of these elements in the cystic wall suggest that 
they could contribute to cystic expansion and disease 
progression. Anyway as far as now no evidence is avail- 
able to sustain the hypothesis that CD133+ and CD24+ 
cystic cells are progenitors migrated into the cystic wall 
rather than the alternative hypothesis that they represent 
dedifferentiated [18] tubular cells that express “de novo” 
CD133 and CD24.  
The expression of CD133 and CD24 is maintained in 
cystic cells isolated and cultured in vitro. Furthermore 
we evaluated the expression of these antigens in two tu-
bular immortalized cellular lines, HEK293 and HK2. 
4. CONCLUSION 
In conclusion we demonstrated an abundant popula-
tion of CD133+ CD24+cells in renal tissue obtained 
from ADPKD patients. This cell population is present in 
the cystic wall and abundant in tubules, which con- 
versely seems to be reduced in ADPKD glomerula in 
comparison to normal tissue. The role of this cells was 
not clear yet, but it could be interesting to evaluate more 
cases of ADPKD, in different stages (from asymptomatic 
to late stage), and clarify if CD133+ CD24+cells were 
prognostic factors for a poorer or better evolution of the 
disease. Additionally, we cannot univocally conclude that 
the CD133 + CD24 + cystic cells represent migrated 
renal progenitors rather than tubular dedifferentiated 
cells 18, but with a deeper biomarker analysis we could 
understand their origin and their hypothetical migration. 
Knowing this element will be important to understand 
more in detail pathophysiology of ADPKD and find new 
target to delay the progression of the disease. 
5. MATERIAL AND METHODS 
5.1. Antibodies 
CD133 monoclonal (293C3) antibody for immuno- 
fluorescence was provided by Miltenyi Biotec (Miltenyi 
Biotec, Bergisch Gladbach, Germany). CD133 mono-
clonal (W6B9C1) antibody for Western blot was pro-
vided by Miltenyi Biotec (Miltenyi Biotec, Bergisch 
Gladbach, Germany). CD24 monoclonal (SN3) antibody 
was provided by Santa Cruz (Santa Cruz Biotechnology 
Inc., Santa Cruz CA, USA). PKD1 rabbit polyclonal (H- 
260) antibody was provided by Santa Cruz (Santa Cruz 
Biotechnology Inc., Santa Cruz CA, USA). Goat anti 
mouse IgG2b-Alexa 568 conjugate, goat anti mouse 
IgG2b-Alexa 633 conjugate, goat anti mouse IgG1-Alexa 
568 conjugate, goat anti rabbit IgG-Rhod conjugate, goat 
anti mouse IgG-HRP conjugate were used as secondary 
antibodies. Cytokeratins monoclonal (CAM 5.2, CK7 
[RCK105], CK20 [SPM140] and MNF 116) antibody 
was provided by Becton Dickinson (only CAM 5.2) 
(Becton Dickinson, CA, USA) and Abcam (the others) 
(Abcam, Cambridge, UK). 
5.2. Tissues 
Normal kidney fragments were obtained from a ca-
daveric kidney donor. The kidney was not suitable for 
transplantation due to the incidental discovery of a neo-
plastic nodule of 5 cm at the lower pole upon macro-
scopic examination. The pathologic examination diag-
nosed a clear cell carcinoma (grade 2 according to 
Fuhrman classification; T1bN0M0 according to the In-
ternational Union Against Cancer classification); the 
lower pole was excised and the remaining parenchyma 
was used in the following procedures. The remaining 
parenchyma did not reveal any evidence of clear cell 
carcinoma. 
Polycystic kidney tissue was obtained from 2 ADPKD 
patients underwent to nephrectomy in preparation for 
receiving renal transplantation. All procedures were pre-
ceded by the approval of our Local Ethical Committee on 
human experimentation and informed consent was ob-
tained from the patients. 
5.3. Culture 
Human Kidney 2 cells (HK-2) were maintained in 
DMEM F-12 (Invitrogen/GIBCO, Cralsbad, California) 
supplementated with 10% FBS (PAA laboratories GmbH, 
Pasching, Austria), 2000 U/ml penicillin (PAA laborato-
ries GmbH, Pasching, Austria), 2000 ug/ml streptomycin 
(PAA laboratories GmbH, Pasching, Austria), and 20 mM 
L-glutamine (Invitrogen/GIBCO, Cralsbad, California). 
Human Embryonic Kidney 293 cells (HEK-293) were 
maintained in DMEM (Invitrogen/GIBCO, Cralsbad, 
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California) supplementated with 5% FBS (PAA laborato-
ries GmbH, Pasching, Austria), 2000 U/ml penicillin 
(PAA laboratories GmbH, Pasching, Austria), 2000 ug/ml 
streptomycin (PAA laboratories GmbH, Pasching, Aus- 
tria), and 20 mM L-glutamine (Invitrogen/GIBCO, Crals- 
bad, California). 
HK-2 and HEK-293 were grown two weeks and me-
dium was changed every two days. After every week, 
cells were washed with PBS (PAA laboratories GmbH, 
Pasching, Austria) and were trypsinizated (Invitrogen/ 
GIBCO, Cralsbad, California). Cells harvested were, in 
part, seeded on chambers slides and the others were used 
to extract proteins. 
Cystic cells were obtained by fragments of renal cysts 
deprived of external membrane. Each cyst was picked up, 
was divided in some little fragments and were digested 
by collagenase (Invitrogen/GIBCO, Cralsbad, California) 
for one hours. Every pieces of a single cysts were seeded 
on a plate, previously treated by collagene type I (Invi-
trogen/GIBCO, Cralsbad, California), the same medium 
used for HK-2. 
5.4. Immunofluorescence 
Three-micrometer frozen kidney samples mounted on 
Super Frost Plus slides (Menzel-Gläser, Thermo Scien- 
tific, Waltham, MA) were cut by a cryostat (Leica 1720, 
Leica Mycrosystems, Heerbrog, Germany). The sections, 
or cellular spots, were fixed with PFA for 10 min, 
washed with PBS. Slides were coated (3% Bovine Serum 
Albumin in PBS buffer) for 1 h at 20˚C. Slides were in- 
cubated by primary antibody for 1 h at 37˚C, washed 
with PBS and successively incubated by secondary anti- 
body for 1 h at 20˚C. Primary and secondary antibodies 
were diluted in coating solution. Slides were closed with 
Vectashield® Mounting Medium with DAPI (Vector La- 
boratories, Inc., Burlingame, CA, USA). Tissue samples, 
or cells, were examined by immunofluorescence micro- 
scopy (Olympus BX41 Microscopy). Laser Confocal 
images were obtained with Leica TCS SP2 (Leica Mi- 
crosystems, Heerbrog, Germany). 
5.5. Immunohistochemical 
The same type of sample mounted on slides used for 
immunofluorescence analysis was handled for immuno- 
histochemical evaluation. Slides were coated (3% Bovine 
Serum Albumin in PBS buffer) for 1 h at 20˚C. Slides 
were incubated by primary antibody over night at 4˚C, 
washed with PBS and successively incubated by secon- 
dary antibody (conjugated horse radish peroxidise) by for 
30 min at 20˚C. Hydrogen peroxide and diaminoben- 
zidine (DAB) (SIGMA-ALDRICH, St. Louis, MO, USA) 
were used to obtain chromogen reaction. Olympus BX41 
microscope was used to evaluate the samples. 
5.6. Image Analysis 
Images of immunofluorescence-marked kidney were 
sampled by an acquisition system composed by Olympus 
BX41 microscope, Olympus XC30 and CELL B 3.0 
analysis image processing (Olympus Europa GmbH, 
Hamburg Germany). Images were saved in tagged image 
file format (.tiff). The files were analyzed with Inspector 
Matrox (Matrox Electronic System Ltd., Quebec Can-
ada). ROI (region of interest) defines a portion of image 
that contains areas to analyze. ROI of each renal compo-
nent (tubules, glomeruli and cysts) were sampled and 
converted in a list of single grey tone amount, from white 
(highest value) to black (zero). Background fluorescence 
was obtained sampling spot of negative structure, such 
mesangium or negative tubules, in every image. 
5.7. Statistical Analysis 
Total brightness/positive area ratio was calculated for 
each ROI. The following analysis of expression were 
performed: CD24+ in tubules of normal tissue, CD24+ in 
glomeruli of normal tissue, CD24+ in tubules of ADPKD 
samples, CD24+ in glomeruli of ADPKD samples, 
CD24+ in cysts of ADPKD samples, CD133+ in tubules 
of normal samples, CD133 + in glomeruli of normal tis-
sue, CD133+ in tubules of ADPKD samples, CD133 + in 
glomeruli of ADPKD samples, CD133 + in cysts of 
ADPKD samples. Normal and ADPKD tissue compo-
nents were compare by Mann-Whitney test. Results were 
considered statistically significant for p < 0.01. All statis-
tical analysis were performed with the software SPSS 
Statistics 19.0.1 (IBM corporation, New York, USA). 
5.8. Western Blot Analysis 
Total proteins were extracted from cellular pellets with 
Triton X-100 based lysis buffer. Proteins were loaded on 
SDS-PAGE (3% stacking, 7.5% resolving), previously 
denatured with 4X Reducing Loading Buffer (200mM 
TrisHCl, 20% β-Mercapto Ethanol, 8% SDS, 0.4% Bro-
mofenol Blue, 40% glycerol). After SDS-PAGE run and 
transblot, nitrocellulose membranes were previously in-
cubated by antibodies anti-CD133 and anti-CD24 and 
subsequently by horse radish peroxidise conjugated sec-
ondary antibodies. The detection was obtained by expo-
sition of radiological plates to peroxidise substrate acti-
vated by the enzyme. 
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